Related Experiment Video
Updated: Jul 28, 2026
07:25
Assessing Murine Resistance Artery Function Using Pressure Myography
Published on: June 7, 2013
Hypertension in beta-adducin-deficient mice
M L Marro1, O U Scremin, M C Jordan
1International Center for Genetic Engineering and Biotechnology, Trieste, Italy.
Hypertension (Dallas, Tex. : 1979)
|September 16, 2000
Summary
Beta-adducin deficiency in mice significantly elevates systolic, diastolic, and pulse blood pressure, directly linking adducin gene mutations to hypertension. This study provides the first genetic evidence for adducin
Area of Science:
- Cardiovascular biology
- Genetics
- Molecular biology
Background:
- Polymorphic variants of adducin, a cytoskeletal protein, are linked to hypertension.
- The direct role of adducin in blood pressure regulation remains unestablished.
Purpose of the Study:
- To investigate the direct effect of beta-adducin on arterial blood pressure.
- To determine if beta-adducin deficiency influences cardiovascular parameters.
Main Methods:
- Utilized a beta-adducin-deficient mouse model (-/-) compared to wild-type controls (+/+).
- Measured aortic blood pressure in conscious, freely moving mice using telemetry.
- Analyzed protein levels of adducin isoforms via Western blot.
Main Results:
- Beta-adducin-deficient mice exhibited significantly higher systolic, diastolic, and pulse blood pressure.
- Absence of beta-adducin led to reduced levels of alpha- and gamma-adducin in cardiac tissue.
- No evidence of cardiac remodeling or altered heart function was observed in deficient mice.
Conclusions:
- This study provides the first direct evidence that mutations in the adducin gene family can trigger hypertension.
- Beta-adducin plays a critical role in the regulation of arterial blood pressure.
